Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05829824 · ClinicalTrials.gov registry record · NA
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT05829824 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 400 participants.
The verdict
NCT05829824, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
Interventions
- BEHAVIORAL CareConnect
- OTHER AutoReach
- PROCEDURE Biospecimen samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2025-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05829824
The ClinicalTrials.gov registry entry for NCT05829824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CareConnect is the first listed.
NCT05829824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05829824 about?
NCT05829824 is a clinical study titled "Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach". This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-...
What is the current status of trial NCT05829824?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2023-11-27. Estimated completion is 2025-08-15.
What interventions are being tested in trial NCT05829824?
The interventions under investigation include: CareConnect (BEHAVIORAL), AutoReach (OTHER), Biospecimen samples (PROCEDURE).
Who is sponsoring clinical trial NCT05829824?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.